Americas Antibody Congress: Launching May 27-28, 2015

Announcing the launch of the Americas Antibody Congress

Over the past 10 years we have been working with the antibody industry to create our Antibody Congress series. We have a proud track record in Europe, Asia and now with this knowledge we are launching into America in 2015.

The US is projected to become the largest single market for therapeutic mAbs from $20.1B in 2011 to to $27.4B by 2016. Although there have been a number of mAbs entering the market, with high development costs, and time-consuming R&D and clinical trials making it difficult to gain faster entry into the US market. The therapeutic potential is still enormous. By addressing these issues head on, attendees at the Americas Antibody Congress will have the opportunity to gain insight from industry innovators and disruptors; do business with solution providers in the exhibition; crowd source in roundtable sessions enabling you to tailor your audience to suit your business needs; and also network with your peers with our 1-2-1 partnering system, but also having loads of fun at the Terrapinn garden party.